Home › Hemophilia › Washington
Hemophilia clinical trials in Washington
6 studies for Hemophilia are looking for participants at sites in Washington.
Cities in Washington
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Washington Center for Bleeding Disorders, Seattle
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 4, 2026 · NCT07416604ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Washington Center for Bleeding Disorders, Seattle
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Washington Institute for Coagulation d/b/a WACBD, Seattle
RecruitingPhase 3
Ages 1 to 74 · Men · Updated Jul 1, 2026 · NCT05145127Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Washington Institute for Coagulation, Seattle
RecruitingPhase 3
Ages 18 and older · Men · Updated May 27, 2026 · NCT05568719Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- Washington Center for Bleeding Disorders, Seattle
RecruitingPhase 1
Ages 0 to 90 · All sexes · Updated Apr 3, 2026 · NCT05500807Hemophilia A Research Program
- University of Washington, Seattle
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 17, 2026 · NCT07414511From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.